
Bortero 3.5mg Injection
Marketer
Hetero Drugs Ltd
Salt Composition
Bortezomib (3.5mg)
Overview Bortero 3.5mg Injection
Myeloma and mantle cell lymphoma are treated with the injectable medication, Bortero 3.5mg. Its mechanism involves inhibiting or reducing the proliferation of cancerous cells. Administration is exclusively via injection by a qualified healthcare provider. Dosage and frequency are determined by your physician, depending on your specific condition and may be adjusted. Strict adherence to your doctor's instructions is crucial; improper usage or overdose can lead to severe adverse reactions. While therapeutic benefits might not be immediately apparent (taking several weeks or months), discontinue use only under medical guidance. Common side effects include fatigue, nausea, vomiting, and decreased appetite. Increased daily fluid intake is often recommended. Operating machinery or driving should be avoided due to potential drowsiness and dizziness. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests are essential to monitor blood cell levels, along with heart, liver function, and uric acid. Prior to commencing Bortero 3.5mg, disclose any pre-existing liver, kidney, heart conditions, or bleeding disorders to your physician. Report cognitive symptoms such as memory impairment or difficulty concentrating. Inform your healthcare team of all other medications you are taking, as interactions are possible. Pregnancy and breastfeeding are contraindications. Reliable contraception is vital for both partners during treatment to prevent conception.
Primary Ingredients of Bortero 3.5mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Bortero 3.5mg Injection
Myeloma and mantle cell lymphoma
Major Benefits of Bortero 3.5mg Injection:
Administering this medication will be done by your physician or their qualified nurse; self-medication is strictly prohibited.
Common Side effects of Bortero 3.5mg Injection:
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
How to use Bortero 3.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Bortero 3.5mg Injection works:
OncoBort 3.5mg Injection is a cancer therapy that inhibits protein degradation within cancerous cells. This action elevates intracellular protein levels, ultimately inducing cancer cell apoptosis.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Bortero 3.5mg Injection and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering a 3.5mg Bortero injection during pregnancy poses a confirmed risk to the fetus. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Bortero 3.5mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harmful effects to the nursing infant.
DrivingUNSAFE
Administering a 3.5mg Bortero injection can induce adverse reactions that impair driving capabilities. These reactions may include fatigue, vertigo, syncope, or visual disturbances, potentially affecting driving safety.
KidneyCAUTION
Administering Bortero 3.5mg Injection requires careful consideration in individuals with advanced renal impairment. Dosage modification for Bortero 3.5mg Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
Individuals with hepatic impairment should use the 3.5mg Bortero Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Bortero 3.5mg Injection :
Should you forget a dose of the 3.5mg Bortero injection, seek advice from your physician.
Facts to Know About Bortero 3.5mg Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylalanine-based Compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
